Lv11
50 积分 2023-01-10 加入
Trispecific anti-CD3/BCMA/CD38 antibodies for multiple myeloma: a patent evaluation of US20240132615
9天前
已完结
Trispecific anti-CD3/BCMA/CD38 antibodies for multiple myeloma: a patent evaluation of US20240132615
23天前
已完结
Proximity between LAG-3 and the T cell receptor guides suppression of T cell activation and autoimmunity
25天前
已完结
A Patient-Derived Organoid Screen Identified the Bispecific Antibody MCLA-158
2个月前
已完结
A Trispecific Antibody Induces Potent Tumor-Directed T-Cell Activation and Antitumor Activity by CD3/CD28 Co-Engagement
2个月前
已完结
Platelet-Derived TGF-β1 Induces Functional Reprogramming of Myeloid-Derived Suppressor Cells in Immune Thrombocytopenia
4个月前
已完结
Platelet-Derived TGF-β1 Induces Functional Reprogramming of Myeloid-Derived Suppressor Cells in Immune Thrombocytopenia
4个月前
已关闭
504 CS2009, a novel first-in-class trispecific antibody targeting PD-1, CTLA-4, and VEGFa, demonstrates promising anti-tumor activity in preclinical evaluation
5个月前
已完结
Dinaciclib induces immunogenic cell death and enhances anti-PD1–mediated tumor suppression
7个月前
已完结
Achievable but elusive: LLDAS and DORIS remission in clinical trials of belimumab
8个月前
已完结
皖公网安备34019202002308
